BioMatrix Specialty Pharmacy

What BioMatrix Specialty Pharmacy does

BioMatrix Specialty Pharmacy, operating as LUX Infusion since April 1, 2026, is a privately held specialty pharmacy and ambulatory infusion services platform headquartered in Plantation, Florida. The company operates a national network of owned and operated outpatient infusion centers providing injectable and IV therapies for patients with chronic conditions, including autoimmune disorders, immune deficiencies, and post-transplant medication regimens. In 2025, the company supported over 800 transplant patients across 42 states with a documented 14-day start-of-care timeline from referral to therapy initiation, alongside an ambulatory infusion footprint spanning 11+ centers across at least five states following a series of acquisitions (LUX Infusion in Alaska, Total Infusion Care in Nevada, First Choice Wellness Centers in the Southeast).

The company's technology stack centers on the Plenful AI-powered workflow automation platform, deployed in September 2025, which automates intake authorization management, fax processing, data extraction, benefit verification, prior authorization submission, and 340B compliance using pharmacy-specialized large language models and intelligent document processing. Reported outcomes include a more than 75% reduction in authorization processing time and a quadrupling of team capacity. The platform integrates into existing pharmacy workflows and is positioned as a core operational partnership rather than an in-house AI build.

BioMatrix generates revenue through two primary streams: ambulatory infusion services delivered via company-owned centers under a professional services billing model, and specialty pharmacy dispensing (notably for transplant pharmaceuticals) under a managed services model. Services are billed through insurance, Medicare, and Medicaid based on contracted payer rates; pricing is not publicly disclosed. Go-to-market is sales-led and built on relationship-based referral networks with transplant programs, rheumatologists, neurologists, and other specialists, supplemented by payer and health system contracts. Leadership includes CEO Kathee Kramm, CFO Joseph Ziegler, and Chief Growth Officer William Nolan; Heidi Ulbrich was promoted to Transplant Services Program Manager in February 2026. The company raised $80M in a 2016 funding round and has executed multiple acquisitions since 2020 (City Drugs, InfuCare, Mylyfe Specialty Pharmacy, LUX Infusion, Total Infusion Care, First Choice Wellness Centers).

Name

BioMatrix Specialty Pharmacy

Legal name

BioMatrix Infusion Pharmacy

Website

http://www.biomatrixsprx.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

BioMatrix Specialty Pharmacy (now operating as LUX Infusion) is a privately held specialty pharmacy and ambulatory infusion platform operating 11+ owned outpatient infusion centers across the US, serving chronic disease and transplant patients in 42 states.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy and Ambulatory Infusion Services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Infusion & Home Infusion Pharmacy Services (HLAFALAG)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

Keywords

• Specialty pharmacy
• Ambulatory infusion
• Transplant services
• Infusion therapy
• Specialty medications

Headquarters

HQ city

Plantation

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Ambulatory Infusion Services: Revenue generated from operating outpatient infusion centers providing medication administration services to patients with chronic conditions requiring injectable or infusion therapies
2. Specialty Pharmacy Dispensing: Revenue from dispensing specialty medications, including transplant-related pharmaceuticals, with an industry-leading 14-day start of care from referral to therapy initiation

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

BioMatrix Specialty Pharmacy operates a national network of company-owned ambulatory infusion centers and specialty pharmacy services, providing outpatient infusion therapy for chronic conditions (autoimmune disorders, immune deficiencies, biologics) and specialized transplant medication management. Services are accessed via physician and specialist referrals, with payer contracts (insurance, Medicare, Medicaid) covering infusion administration and specialty medication dispensing. Operations are supported by the Plenful AI-powered workflow automation platform that streamlines prior authorization, intake, benefit verification, and 340B compliance.

Product overview

BioMatrix Infusion Pharmacy (rebranded as LUX Infusion as of April 2026) operates a network of infusion centers and specialty pharmacy services across the United States. The core offering is ambulatory infusion therapy services, expanded through multiple strategic acquisitions including LUX Infusion (Pacific Northwest/Alaska), Total Infusion Care (Nevada/western U.S.), and First Choice Wellness Centers (Southeast). The company also runs a Transplant Services Program supporting over 800 patients annually across 42 states. Operations leverage the Plenful AI workflow automation platform for intake authorization management, benefit verification, and 340B compliance, achieving significant efficiency gains. Following the April 2026 rebrand, all locations and services unified under the LUX Infusion name.

Differentiator

Problem solved

Functional benefit

Products and services

• Ambulatory Infusion Services Outpatient infusion therapy services providing administration of specialty injectable and IV medications (immunoglobulin, biologics) for patients with chronic conditions including autoimmune disorders and immune deficiencies. Services are accessed via specialist referrals at community-based infusion centers.
• Transplant Services Program Specialized pharmacy program supporting transplant patients with medication management, pre- and post-transplant care coordination, and therapy initiation. Coordinates with transplant programs, specialists, and payers across 42 states with an industry-leading 14-day start of care benchmark.
• Specialty Pharmacy Dispensing Dispensing of specialty pharmaceuticals, including transplant-related medications, supported by Plenful AI workflow automation for intake authorization, prior authorization, benefit verification, and 340B compliance. Achieves 75% processing time reduction and 4x capacity increase.

Quantifiable outcome

• Reduced intake authorization processing time by more than 75% through AI automation
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature1 record

Partnerships

One partnership is on record.

• PlenfulcoreTechnology or Integration · 11 September 2025Plenful provides AI-powered intake authorization management automation to BioMatrix Specialty Infusion Pharmacy. The platform reduces processing time by more than 75% and quadruples team capacity through automated fax processing, data extraction, benefit verification, and prior authorization submission using large language models and intelligent document processing. This technology partnership enables operational efficiency improvements across the company's specialty and infusion pharmacy operations.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S., with a national footprint and a similar specialty pharmacy + infusion model focused on chronic and complex therapies — directly comparable to BioMatrix's ambulatory infusion and specialty pharmacy offering.
• Soleo Health: Specialty infusion pharmacy and home infusion services provider focused on complex conditions including immunoglobulin therapy, biologics, and chronic disease management — overlapping with BioMatrix's ambulatory infusion and specialty pharmacy product mix.
• Amerita: Specialty infusion pharmacy serving patients with chronic and complex conditions across multiple states, with services spanning infusion, injectable, and enteral therapies — directly comparable business model and patient population to BioMatrix.
• IVX Health: Outpatient infusion center network providing IV therapy for chronic conditions in a community-based setting — directly comparable physical infusion center model and patient experience to BioMatrix's infusion center operations.
• Vivo Infusion: Outpatient infusion therapy provider operating a network of community-based infusion centers across multiple states — directly comparable site-of-care strategy and specialty therapy focus.
• Vital Care Infusion Services: Franchise-based ambulatory infusion network providing specialty infusion therapies across the U.S. — directly comparable community infusion center model serving similar chronic disease populations.
• Nufactor: Specialty infusion pharmacy focused on hemophilia, immune deficiencies, and complex chronic conditions — overlapping with BioMatrix's specialty pharmacy dispensing for complex and biologic therapies.

Broad incumbents

• Accredo (Express Scripts): Specialty pharmacy arm of one of the largest PBMs in the U.S., offering nationwide dispensing of specialty and biologic medications including transplant and infusion therapies — a large incumbent with overlapping capabilities but broader portfolio.
• CVS Specialty (Caremark): Specialty pharmacy division of CVS Health, providing nationwide specialty medication dispensing and infusion services through a vertically integrated payer/PBM/retail network — broad incumbent competing for the same specialty therapy prescriptions.
• Walgreens Specialty Pharmacy: Specialty pharmacy operations of one of the largest U.S. pharmacy retailers, dispensing specialty and biologic medications across a national footprint — broad incumbent with overlapping specialty pharmacy capabilities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/biomatrixsprx
• Facebookfacebook.com/biomatrixsprx

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioMatrix Specialty Pharmacy